- Format
- E-bog, ePub
- Engelsk
Er ikke web-tilgængelig
E-bogen er DRM-beskyttet og kræver et særligt læseprogram
Normalpris
kr. 634,95
Medlemspris
kr. 589,95
Beskrivelse
As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator's biologic products. But scientific challenges remain due to the complexity of both the manuf
Detaljer
- SprogEngelsk
- Sidetal444
- Udgivelsesdato29-07-2013
- ISBN139781040189108
- Forlag Crc Press
- FormatePub
Anmeldelser
Vær den første!
Log ind for at skrive en anmeldelse.